Quiros-Roldan E - Search Results

1

Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort.

d'Arminio Monforte A, Tavelli A, Rossotti R, Gagliardini R, Saracino A, Lo Caputo S, Sala M, Quiros-Roldan E, Mussini C, Girardi E, Cozzi-Lepri A, Antinori A, Puoti M; NoCo Study of the Icona cohort. d'Arminio Monforte A, et al. Liver Int. 2023 Oct;43(10):2130-2141. doi: 10.1111/liv.15700. Epub 2023 Aug 31. Liver Int. 2023. PMID: 37649460 Free article.

2

Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment.

Puoti M, Gargiulo F, Quiros Roldan E, Chiodera A, Palvarini L, Spinetti A, Zaltron S, Putzolu V, Zanini B, Favilli F, Turano A, Carosi G. Puoti M, et al. J Infect Dis. 2000 Jun;181(6):2033-6. doi: 10.1086/315529. Epub 2000 May 31. J Infect Dis. 2000. PMID: 10837187

3

Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients.

Quiros-Roldan E, Moretti F, Airoldi M, Fausti C, Chiodera A, Castelli F, Carosi G. Quiros-Roldan E, et al. J Clin Lab Anal. 2001;15(3):127-30. doi: 10.1002/jcla.1015. J Clin Lab Anal. 2001. PMID: 11344527 Free PMC article.

4

[New strategies and new drugs in the salvage therapy for HIV infection].

Quirós-Roldán E, Torti C, Pan A, Carosi G. Quirós-Roldán E, et al. Med Clin (Barc). 2002 Feb 23;118(6):222-4. doi: 10.1016/s0025-7753(02)72341-5. Med Clin (Barc). 2002. PMID: 11864546 Review. Spanish. No abstract available.

5

Oesophagobronchial fistula caused by varicella zoster virus in a patient with AIDS: a unique case.

Moretti F, Uberti-Foppa C, Quiros-Roldan E, Fanti L, Lillo F, Lazzarin A. Moretti F, et al. J Clin Pathol. 2002 May;55(5):397-8. doi: 10.1136/jcp.55.5.397. J Clin Pathol. 2002. PMID: 11986352 Free PMC article.

6

Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study.

Patroni A, Torti C, Tomasoni L, Quiros Roldan E, Bertelli D, Puoti M, Cadeo GP, Sleiman I, Tinelli C, Carosi G, Castelli F. Patroni A, et al. HIV Clin Trials. 2002 Nov-Dec;3(6):451-61. doi: 10.1310/w024-qc4t-nxu0-tkyt. HIV Clin Trials. 2002. PMID: 12501128

7

Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.

Mazzotta F, Lo Caputo S, Torti C, Tinelli C, Pierotti P, Castelli F, Lazzarin A, Angarano G, Maserati R, Gianotti N, Ladisa N, Quiros-Roldan E, Rinehart AR, Carosi G; Genotipo-Fenotipo di Resistenza (GenPheRex) Group of the Italian Management Standardizzato di Terapia Antiretrovirale (MASTER) Cohort. Mazzotta F, et al. J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):268-80. doi: 10.1097/00126334-200303010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12626886 Clinical Trial.

8

HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations.

Scudeller L, Torti C, Quiros-Roldan E, Patroni A, Lo Caputo S, Moretti F, Mazzotta F, Donati E, Vivarelli A, Carosi G; GenPheRex Group of the MASTER Cohort. Scudeller L, et al. J Antimicrob Chemother. 2003 Nov;52(5):776-81. doi: 10.1093/jac/dkg456. Epub 2003 Oct 16. J Antimicrob Chemother. 2003. PMID: 14563897 Clinical Trial.

9

Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.

Torti C, Barnes E, Quiros-Roldan E, Puoti M, Carosi G, Klenerman P. Torti C, et al. Antivir Ther. 2004 Feb;9(1):139-42. Antivir Ther. 2004. PMID: 15040546 No abstract available.

10

Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients.

Torti C, Quiros-Roldan E, Monno L, Patroni A, Saracino A, Angarano G, Tinelli C, Lo Caputo S, Tirelli V, Mazzotta F, Carosi G; MASTER Cohort GenPheRex Study Group; MASTER Cohort PhenGen Study Group. Torti C, et al. J Med Virol. 2004 Sep;74(1):29-33. doi: 10.1002/jmv.20142. J Med Virol. 2004. PMID: 15258965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page